Protein carbonylation, cellular dysfunction, and disease progression

By I. Dalle-Donne, G. Aldini, M. Carini, R. Colombo, R. Rossi, A. Milzani. Journal of Cellular and Molecular Medicine, 2006

850 citations recorded by the source corpus.

Carbonylation of proteins is an irreversible oxidative damage, often leading to a loss of protein function, which is considered a widespread indicator of severe oxidative damage and disease‐derived protein dysfunction. Whereas moderately carbonylated proteins are degraded by the proteasomal system, heavily carbonylated proteins tend to form high‐molecular‐weight aggregates that are resistant to degradation and accumulate as damaged or unfolded proteins. Such aggregates of carbonylated proteins can inhibit proteasome activity. A large number of neurodegenerative diseases are directly associated with the accumulation of proteolysis‐resistant aggregates of carbonylated proteins in tissues. Identification of specific carbonylated protein(s) functionally impaired and development of selective carbonyl blockers should lead to the definitive assessment of the causative, correlative or consequential role of protein carbonylation in disease onset and/or progression, possibly providing new therapeutic aproaches.

Subfields: Clinical Biochemistry, Molecular Biology, Physiology

View Paper: https://www.semanticscholar.org/paper/4b28b09dc1c8ee2b4f7aa570bc680bd917b64610

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

  1. M. Davies

In Molecular Biology

  1. M. Davies

In Physiology

  1. M. Davies
  2. Chunyan Guo
  3. J. Kong
  4. Xueping Chen

Citations in the corpus